Comment
doi: 10.1038/ncb1008-1127.One hit, two outcomes for VHL-mediated tumorigenesis
Affiliations
- PMID:18830218
- DOI: 10.1038/ncb1008-1127
Item in Clipboard
Comment
One hit, two outcomes for VHL-mediated tumorigenesis
Jürgen Behrens. Nat Cell Biol.2008 Oct.
Display options
Format
Display options
Format
No abstract available
Comment on
- Jade-1 inhibits Wnt signalling by ubiquitylating beta-catenin and mediates Wnt pathway inhibition by pVHL.Chitalia VC, Foy RL, Bachschmid MM, Zeng L, Panchenko MV, Zhou MI, Bharti A, Seldin DC, Lecker SH, Dominguez I, Cohen HT.Chitalia VC, et al.Nat Cell Biol. 2008 Oct;10(10):1208-16. doi: 10.1038/ncb1781. Epub 2008 Sep 21.Nat Cell Biol. 2008.PMID:18806787Free PMC article.
Similar articles
- Jade-1 inhibits Wnt signalling by ubiquitylating beta-catenin and mediates Wnt pathway inhibition by pVHL.Chitalia VC, Foy RL, Bachschmid MM, Zeng L, Panchenko MV, Zhou MI, Bharti A, Seldin DC, Lecker SH, Dominguez I, Cohen HT.Chitalia VC, et al.Nat Cell Biol. 2008 Oct;10(10):1208-16. doi: 10.1038/ncb1781. Epub 2008 Sep 21.Nat Cell Biol. 2008.PMID:18806787Free PMC article.
- Beta-catenin gets jaded and von Hippel-Lindau is to blame.Berndt JD, Moon RT, Major MB.Berndt JD, et al.Trends Biochem Sci. 2009 Mar;34(3):101-4. doi: 10.1016/j.tibs.2008.12.002. Epub 2009 Feb 11.Trends Biochem Sci. 2009.PMID:19217300
- Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.Krieg M, Haas R, Brauch H, Acker T, Flamme I, Plate KH.Krieg M, et al.Oncogene. 2000 Nov 16;19(48):5435-43. doi: 10.1038/sj.onc.1203938.Oncogene. 2000.PMID:11114720
- Beyond the hypoxia-inducible factor-centric tumour suppressor model of von Hippel-Lindau.Roberts AM, Ohh M.Roberts AM, et al.Curr Opin Oncol. 2008 Jan;20(1):83-9. doi: 10.1097/CCO.0b013e3282f310de.Curr Opin Oncol. 2008.PMID:18043261Review.
- The von Hippel-Lindau tumour suppressor protein: O2 sensing and cancer.Kaelin WG Jr.Kaelin WG Jr.Nat Rev Cancer. 2008 Nov;8(11):865-73. doi: 10.1038/nrc2502. Epub 2008 Oct 16.Nat Rev Cancer. 2008.PMID:18923434Review.
Cited by
- p21 loss blocks senescence following Apc loss and provokes tumourigenesis in the renal but not the intestinal epithelium.Cole AM, Ridgway RA, Derkits SE, Parry L, Barker N, Clevers H, Clarke AR, Sansom OJ.Cole AM, et al.EMBO Mol Med. 2010 Nov;2(11):472-86. doi: 10.1002/emmm.201000101.EMBO Mol Med. 2010.PMID:20976827Free PMC article.
- MicroRNA-566 activates EGFR signaling and its inhibition sensitizes glioblastoma cells to nimotuzumab.Zhang KL, Zhou X, Han L, Chen LY, Chen LC, Shi ZD, Yang M, Ren Y, Yang JX, Frank TS, Zhang CB, Zhang JX, Pu PY, Zhang JN, Jiang T, Wagner EJ, Li M, Kang CS.Zhang KL, et al.Mol Cancer. 2014 Mar 20;13:63. doi: 10.1186/1476-4598-13-63.Mol Cancer. 2014.PMID:24650032Free PMC article.
- A molecular signature of normal breast epithelial and stromal cells from Li-Fraumeni syndrome mutation carriers.Herbert BS, Chanoux RA, Liu Y, Baenziger PH, Goswami CP, McClintick JN, Edenberg HJ, Pennington RE, Lipkin SM, Kopelovich L.Herbert BS, et al.Oncotarget. 2010 Oct;1(6):405-422. doi: 10.18632/oncotarget.175.Oncotarget. 2010.PMID:21311097Free PMC article.
- The epigenetic landscape of renal cancer.Morris MR, Latif F.Morris MR, et al.Nat Rev Nephrol. 2017 Jan;13(1):47-60. doi: 10.1038/nrneph.2016.168. Epub 2016 Nov 28.Nat Rev Nephrol. 2017.PMID:27890923Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources